Scientific paper - Original scientific paper
Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection
Journal of Clinical Medicine, 11 (2022), 22; 6695. https://doi.org/10.3390/jcm11226695

Krpina, Kristina; Mavrinac, Martina; Samaržija, Miroslav; Tolić, Ena; Darapi, Dora; Batičić, Lara

Cite this document

Krpina, K., Mavrinac, M., Samaržija, M., Tolić, E., Darapi, D. & Batičić, L. (2022). Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection. Journal of Clinical Medicine, 11. (22). doi: 10.3390/jcm11226695

Krpina, Kristina, et al. "Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection." Journal of Clinical Medicine, vol. 11, no. 22, 2022. https://doi.org/10.3390/jcm11226695

Krpina, Kristina, Martina Mavrinac, Miroslav Samaržija, Ena Tolić, Dora Darapi and Lara Batičić. "Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection." Journal of Clinical Medicine 11, no. 22 (2022). https://doi.org/10.3390/jcm11226695

Krpina, K., et al. (2022) 'Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection', Journal of Clinical Medicine, 11(22). doi: 10.3390/jcm11226695

Krpina K, Mavrinac M, Samaržija M, Tolić E, Darapi D, Batičić L. Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection. Journal of Clinical Medicine [Internet]. 2022 [cited 2024 December 06];11(22). doi: 10.3390/jcm11226695

K. Krpina, M. Mavrinac, M. Samaržija, E. Tolić, D. Darapi and L. Batičić, "Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection", Journal of Clinical Medicine, vol. 11, no. 22, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:583604. [Accessed: 06 December 2024]

Please login to the repository to save this object to your list.